MedPath

Validation and Assessment of Novel Morphology-Voltage-P-wave Score for Diagnosing Left Ventricular Diastolic Dysfunction in Patients With Hypertension

Recruiting
Conditions
Hypertension
Registration Number
NCT06779513
Lead Sponsor
Universitas Diponegoro
Brief Summary

This study aimed to assess and validate the diagnostic utility of a novel Morphology-Voltage-P-wave Score (MVP Score) in identifying left ventricular diastolic dysfunction among patients with hypertension.

Researchers will collect information of patient with hypertension and underwent transthoracal echocardiography assessment. The data consist of demographic data, clinical presentation, laboratory, and echocardiography result were collected by two investigators. Then, the data was analyzed by using IBM SPSS Statistics v26.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Essential hypertension
Exclusion Criteria
  • Secondary or resistant hypertension
  • LVEF<55%
  • Congenital heart disease
  • Infiltrative cardiomyopathy
  • Coronary artery disease
  • Chronic kidney disease
  • Valvular heart disease
  • Bundle branch block
  • Arrhythmia

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Diastolic DysfunctionUp to 1 weeks

Diastolic Dysfunction found in transthoracal echocardiography assessment

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Dr. Kariadi Central General Hospital

🇮🇩

Semarang, Central Of Java, Indonesia

© Copyright 2025. All Rights Reserved by MedPath